Monoclonal antibodies specific for human OX40L (CD 134L)

Details for Australian Patent Application No. 2005229009 (hide)

Owner Abgenix, Inc. Amgen, Inc.

Inventors Kellermann, Sirid-Aimee; Khare, Sanjay D.

Agent Shelston IP

Pub. Number AU-A-2005229009

PCT Pub. Number WO2005/094879

Priority 60/555,396 23.03.04 US

Filing date 23 March 2005

Wipo publication date 13 October 2005

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

26 October 2006 PCT application entered the National Phase

  PCT publication WO2005/094879 Priority application(s): WO2005/094879

25 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005229011-Methods and apparatus providing suction-assisted tissue engagement

2005229008-Compositions and method for alleviating inflammation and oxidative stress in a mammal